BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22136311)

  • 1. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment.
    Park GH; Lee JH; Choi JR; Chang SE
    J Dermatolog Treat; 2013 Aug; 24(4):297-9. PubMed ID: 22136311
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
    Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
    J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
    Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
    J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser.
    Lee WJ; Kim YJ; Noh TK; Chang SE
    J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma.
    Kar HK; Gupta L; Chauhan A
    Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
    Kwon HH; Ohn J; Suh DH; Park HY; Choi SC; Jung JY; Kwon IH; Park GH
    J Dermatolog Treat; 2017 Mar; 28(2):155-159. PubMed ID: 27346606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy.
    Kim MJ; Kim JS; Cho SB
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):960-2. PubMed ID: 19207672
    [No Abstract]   [Full Text] [Related]  

  • 16. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema.
    Panchaprateep R; Munavalli G
    Lasers Surg Med; 2015 Feb; 47(2):148-55. PubMed ID: 25645645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better clinical results with long term benefits in melasma patients.
    Na SY; Cho S; Lee JH
    J Dermatolog Treat; 2013 Apr; 24(2):112-8. PubMed ID: 21801110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
    Polnikorn N
    J Cosmet Laser Ther; 2010 Jun; 12(3):126-31. PubMed ID: 20482238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.